GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Akzo Nobel N.V. (ADR) (AKZOY) [hlAlert]

Rating:
Overweight
AKZOY
down 8.77 %

Akzo Nobel N.V. (ADR) (AKZOY) upgraded to Overweight by JP Morgan

Posted on: Friday,  Nov 8, 2013  8:25 AM ET by JP Morgan

JP Morgan rated Overweight Akzo Nobel N.V. (ADR) (OTCBB: AKZOY) on 11/08/2013, when the stock price was $24.72.
Since then, Akzo Nobel N.V. (ADR) has lost 8.78% as of 08/27/2015's recent price of $22.55.
If you would have followed this JP Morgan's recommendation on AKZOY, you would have lost 8.77% of your investment in 657 days.

Akzo Nobel N.V. (AkzoNobel) is a global paints and coatings company and a producer of specialty chemicals. The Company operates in three segments: Decorative Paints, Performance Coatings and Specialty Chemicals. During the year ended December 31, 2009, the Company two distributors in Continental Europe. During 2009, it also acquired SABA, Kronospan and Dow Powder Coatings assets. During 2009, it also divested Chemcraft Brazil and the non-stick businesses. In January 2009, the Company completed the acquisition of LII Europe.

JPMorgan is a leading financial services firm with one of the largest client franchises in the world. We partner with our clients to offer the most complete and innovative solutions in the industry to help them achieve their goals. For more than 200 years, we have taken a long-term approach to our clients and to the way we conduct business. Our firm has grown considerably in scale and scope, but our commitment to our core principle of doing "only first-class business... in a first-class way" has never been stronger.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/8/2013 8:25 AM Buy
None
24.72
as of 12/13/2013
1 Week up  0.12 %
1 Month down  -2.39 %
3 Months down  -1.09 %
1 YTD down  -1.09 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/24/2013 8:25 AM Hold
None
22.78

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy